Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis

Using causal methods, our study is the first and largest suggesting that sildenafil might have benefits among SSc patients regarding diastolic dysfunction and altered ejection fraction occurrence. However, further studies assessing the effect of vasodilators on heart-related outcome among SSc patients are needed to confirm those exploratory results.

Authors

Institutions

Publication Details

Journal
RMD Open
Published
2024-12-01
DOI
https://doi.org/10.1136/rmdopen-2024-004918
Citations
3
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
1.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis

Denis Wahl, Élisabeth Diot, Jean Baptiste Gaultier, Achille Aouba et al.
3 citations
RMD Open
Systemic Sclerosis and Related Diseases
1.27
article

Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis

Denis Wahl, Élisabeth Diot, Jean Baptiste Gaultier, Achille Aouba, Luc Mouthon, Ariel Cohen, David Launay, Vincent Cottin, T. Papo, Eric HACHULLA, Olivier Espitia, Zahir Amoura, Alexis F. Guédon, G. Pugnet, Yannick Allanore, Jean‐Christophe Lega, Olivier Lidove, C. Agard, Benjamin Chaigne, Marie-Hélène Balquet, P. Kieffer, Emmanuel Chatelus, A. Mékinian, A. Hot, B. Granel, N. Magy‐Bertrand, Bernard Bonnotte, Alain Lescoat, Fabrice Carrat, Alain Le Quellec, Olivier Fain, Anne Laure Fauchais, V. Queyrel, Sébastien Rivière, Jean‐Emmanuel Kahn, Robin Dhôte
article en
3 citations

Abstract

Using causal methods, our study is the first and largest suggesting that sildenafil might have benefits among SSc patients regarding diastolic dysfunction and altered ejection fraction occurrence. However, further studies assessing the effect of vasodilators on heart-related outcome among SSc patients are needed to confirm those exploratory results.

RMD OpenVol. 10(4)
Inserm (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Centre Hospitalier Universitaire de Nice (FR), Centre Hospitalier Universitaire de Nantes (FR), Sorbonne Université (FR), Assistance Publique Hôpitaux de Marseille (FR), Centre Hospitalier Universitaire de Besançon (FR), Hôpital Cochin (FR), Centre Hospitalier Universitaire de Montpellier (FR), Centre Hospitalier Universitaire de Tours (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Hôpital Saint-Antoine (FR), Centre Hospitalier de Lens (FR), Groupe Hospitalier Diaconesses Croix Saint-Simon (FR), Centre Hospitalier Universitaire de Caen Normandie (FR), CHU Dijon Bourgogne (FR), Centre Hospitalier Universitaire de Limoges (FR), Centre d'Immunologie et des Maladies Infectieuses (FR), Hôpital Avicenne (FR), Services déconcentrés d'appui à la recherche Val de Loire (FR), Hôpital Ambroise-Paré (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Hôpital Louis Pradel (FR), Hôpital Bichat-Claude-Bernard (FR), Hôpitaux Universitaires de Strasbourg (FR), Groupe Hospitalier de la Région de Mulhouse et Sud Alsace (FR), Centre Hospitalier Universitaire de Rennes (FR), Centre Hospitalier Universitaire de Saint-Étienne (FR), Université de Caen Normandie (FR)
Good health and well-being
Openalex Percentile: Top 19%
Systemic Sclerosis and Related Diseases
1.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.